We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

2 Of King's Skelaxin Patents Invalidated

Law360 (January 21, 2009, 12:00 AM EST) -- A federal judge has invalidated two of King Pharmaceuticals Inc.'s patents that cover the muscle relaxant Skelaxin, although the company still has one patent for the drug not affected by the...
To view the full article, register now.